International Journal of Medical and Oral Research

REVIEW ARTICLE
Year
: 2021  |  Volume : 6  |  Issue : 1  |  Page : 22--23

Recent advances in pulpotomy medicament


Pratik Surana1, Ankita Khandelwal2, Ruchi Gopal3, Rohit R Koppalkar4, Sadia Aafreen5, Shubham Gupta6 
1 Senior Lecturer, Department of Pedodontics and Preventive Dentistry, Maitri College of Dentistry and Research Center, Bhilai, Chhattisgarh, India
2 Consultant Pediatric Dentist, Pune, Maharashtra, India
3 Senior Lecturer, Department of Pedodontics and Preventive Dentistry, Rungta College of Dental Sciences and Research, Bhilai, Chhattisgarh, India
4 Consultant Pediatric Dentist, Gadag, Karnataka, India
5 Consultant Pediatric Dentist, Bhilai, Chhattisgarh, India
6 RK Dental Clinic, Raniganj, West Bengal, India

Correspondence Address:
Dr. Pratik Surana
Department of Pedodontics and Preventive Dentistry, Maitri College of Dentistry and Research Center, GE Road, Anjora, Durg - 491 001, Chhattisgarh
India

Pulpotomy is the most commonly used treatment modality used in cariously involved primary vital primary teeth. Formocresol shows a good clinical success rate over the period of years but concerns raised due to its toxicity, mutagenicity, and carcinogenicity. The current review of literature provides an overview of recent advances in pulpotomy medicament that can be used as an alternative to formocresol.


How to cite this article:
Surana P, Khandelwal A, Gopal R, Koppalkar RR, Aafreen S, Gupta S. Recent advances in pulpotomy medicament.Int J Med Oral Res 2021;6:22-23


How to cite this URL:
Surana P, Khandelwal A, Gopal R, Koppalkar RR, Aafreen S, Gupta S. Recent advances in pulpotomy medicament. Int J Med Oral Res [serial online] 2021 [cited 2021 Dec 3 ];6:22-23
Available from: http://www.ijmorweb.com/article.asp?issn=2772-4883;year=2021;volume=6;issue=1;spage=22;epage=23;aulast=Surana;type=0